CyndRx
Medical Equipment ManufacturingView the employees at
CyndRx-
Denny Lawson Chief Commercialization Officer at CyndRX
-
Springfield, Missouri, United States
-
Rising Star
Ken Truong Clinical Sales/Research Specialist-
Raleigh, North Carolina, United States
-
Rising Star
michael bluett Vice President Clinical Affairs at CyndRX-
Jacksonville, Florida, United States
-
Top 1%
Mike Shipp Information Technology Specialist at CyndRX-
Normandy, Tennessee, United States
-
Rising Star
John Shipp Chief Executive Officer at CyndRX-
United States
-
Top 5%
Overview
CyndRx focuses on medical technology projects achievable within a 1-4 year timeline. Our goal is to develop innovative and disruptive technologies leveraging our in-house industry experiences and expertise to provide high-value return of investment. Currently, CyndRx is fully dedicated to the development and commercialization of a market-differentiating vascular closure device platform, AbsorbaSeal™. AbsorbaSeal™ , a Vascular Closure Device (VCD) platform, virtually eliminates the learning curve of VCDs with its very easy-to-use delivery and deployment, achieves safe and effective hemostasis with a bioabsorbable sealing mechanism that allows the target vessel to heal without chronic implants, while also focusing on economic value. The AbsorbaSeal™ VCD platform is scalable from small through large bore access (5F to 24F), offering the most innovative, clinically and economically valuable VCD platform to date.
-